MACH7 TECHNOLOGIES LIMITED — Board/Management Information 2023

Oct 24, 2023

ASX Announcement

25 October 2023

==> picture [104 x 26] intentionally omitted <==

APPOINTMENT OF NEW CHAIR

Mach7 Technologies Limited (“M7T” or “the Company”) (ASX:M7T), a company specialising in innovative imaging software solutions, today announces the appointment of Robert Bazzani as Chair, effective from the close of the Annual General Meeting (AGM) on 16 November 2023.

Mr Bazzani has been an Independent Non-Executive Director of Mach7 since January 2020. He is currently Chair of the Audit and Risk Management Committee and a member of the Remuneration and Nomination Committee. During a 20-year career at global consulting firm KPMG, Mr Bazzani played a significant role in advising clients on commercial matters, corporate governance, investment banking and law. He has a proven track record in leading and growing large scale and complex businesses and deep industry knowledge across financial services, wealth management and technology. Mr Bazzani is currently a director of Keypath Education International Inc (ASX:KED) and was a director of Class Ltd (ASX:CL1). He holds a Bachelor of Science, Bachelor of Laws and MBA from Monash University.

Mr Bazzani replaces outgoing Chair David Chambers who will retire at the close of the 2023 AGM as announced on 10 August 2023.

Incoming Chair Rob Bazzani said: “I am delighted to become Chair at an exciting time for Mach7 as the Company continues to grow its sales pipeline and deliver strategically important contract wins. I look forward to working with Mike and his team as we take advantage of the opportunities created by a fragmented imaging market and ongoing shift from acute to ambulatory care settings. I would also like to thank David for his contribution to the Company and wish him well in his future endeavours.”

CEO of Mach7 Mike Lampron said: “Since joining the Board in January 2020, Rob’s guidance and strong financial, legal and strategic capabilities have proved invaluable and I look forward to working closely with him as Chair. As a Board, we have embraced this renewal process and the independent thinking, new perspectives, and diversity that come along with it. I believe that with Rob as Chair and Rebecca Thompson joining the Board, we will have the right mix of experience and new capacity on our Board.”

Released on authority of the Board by:

Mike Lampron Managing Director and Chief Executive Officer

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com

ASX Announcement

==> picture [104 x 26] intentionally omitted <==

For more information, contact:

Investor Relations

Françoise Dixon +61 (0) 412 292 977 ir@mach7t.com

About Mach7 Technologies:

Mach7 Technologies (ASX:M7T), founded in 2007, is a medical imaging systems provider that develops innovative image management and viewing solutions for healthcare organizations. The core of these offerings is the Mach7 Enterprise Imaging Solution, encompassing Enterprise Data Management, Enterprise Diagnostic Viewing and Departmental Workflow applications. Mach7’s Enterprise Data Management solution, consisting of a powerful Vendor Neutral Archive (VNA) and data administration tools, allows for the fast storage, access, retrieval and viewing of images across a healthcare network with connectivity to the Cloud. In July 2020, Mach7 acquired Client Outlook and the eUnity Enterprise Diagnostic Viewing technology to augment Mach7’s Enterprise Data Management and Departmental Workflow applications. eUnity is a zerofootprint, FDA-approved, image viewing solution that makes images accessible on any workstation. This offers healthcare professionals consolidated access to all patient images and data, ensuring clinical staff have timely access to the right information to diagnose and treat patients. Uniquely, the company also gives customers independence to deploy its solutions either on a component basis or in a unified comprehensive platform. With more than 165 customers across 15 different countries, Mach7 has built a global network of diverse customers that range from expansive Integrated Delivery Networks, National Health Systems, medical research facilities, and large academic medical institutions to regional community hospitals, private radiology practices, and independent provider groups. Visit Mach7t.com.

Mach7 Technologies Limited (ASX:M7T) ABN: 26 007 817 192 Registered Office: Level 4, 96 – 100 Albert Road, South Melbourne, VIC 3205 T: 03 9692 7222 www.mach7t.com